Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)

Quetzal Therapeutics, a biopharmaceutical company specializing in developing transformative treatments for rare diseases, announced the initiation of a pivotal Phase III clinical trial of QTX-2101, an ...
Johns Hopkins University Applied Physics Laboratory

Johns Hopkins APL and Microsoft’s AI Agent Orchestrates Robotic Teams

APL and Microsoft recently demonstrated an AI agent that can coordinate heterogeneous robot teams using large language models ...
Hosted on MSN

Apellis Pharmaceuticals’ Promising Phase 2 Study on Geographic Atrophy Treatment

Apellis Pharmaceuticals ((APLS)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Newsable Asianet News on MSN

Archery Premier League wins 'Emerging Sports Event of the Year' award

The Archery Premier League (APL) won the 'Emerging Professional Sports Event of the Year' at the India Sports Awards 2025. The world's first pro archery league was lauded for its successful debut ...